A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT02175784 · COMPLETED
Trial details
- NCT number
- NCT02175784
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-31
- Primary completion
- 2015-03-31
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.